How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue

July 11, 2023

This article was published in Innovative Veterinary Care Journal.

---

IMPROVE YOUR CLINICAL SUCCESS RATE

One way to increase your practice revenue is to improve clinical success rates. However, cancer is one ailment that can prove to be a nemesis for veterinarians since remission rates are low and prescribed drugs may or may not work. Clients who hope to see their pets recover as soon as possible are disappointed when told the treatment path has to be changed.

But what if you could experience a high percentage of clinical remissions and happy clients with the very first treatment? Along with the professional satisfaction that comes with a higher success rate, your reputation will grow, and clients will start referring friends and family with ailing pets to your practice. The inevitable result is increased revenue.

By partnering with ImpriMed, you can start overcoming cancer by raising remission rates in your patients. This precision medicine company has developed a state-of-the-art AI platform that uses real-world clinical data to make drug response predictions for each individual patient. ImpriMed is currently offering personalized drug response prediction profiles for both canine lymphoma and leukemia.

DETERMINING THE BEST CANCER DRUGS FOR YOUR PATIENTS

ImpriMed’s drug response prediction profile informs you of the most suitable cancer drugs for each patient, along with expected remission times. It’s curated by advanced AI tools that have been trained by chemosensitivity and other patient data. Information from live patient cells is also added to the platform to get the best possible individualized drug response predictions. An ingenious robotic machine is used to drop drugs onto the live cancer cells, and the results are recorded. You can expect to have the profile in your hands within seven days of sample collection.

OTHER SERVICES AND TRAINING REQUIREMENTS

ImpriMed offers additional services along with their drug response prediction profile. Get reports for immune profiling using flow cytometry and PCR for antigen receptor rearrangements; flow cytometry only; and PCR for antigen receptor rearrangements only. Free immuno-profiles for cats suffering from lymphoma or leukemia are also being offered.

All you need is to be familiar with the Fine Needle Aspiration (FNA) method for sample collection. You can easily get a FNA refresher by visiting the FAQ section on ImpriMed’s website.

In the News

How Artificial Intelligence Is Revolutionising Cancer Care for Pets

Pets Magazine
Learn More →

Artificial Intelligence Takes on Cancer: The Only AI Dr. Karyn Doesn’t Hate

Dogster
Learn More →

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Pharmacy Times
Learn More →

Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers

Dogster
Learn More →

Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Biopharma Boardroom
Learn More →

From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

Pharmacy Times
Learn More →

ImpriMed unveils cancer treatment forecast technology

MobiHealthNews
Learn More →

New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma

American Animal Hospital Association NEWStat®
Learn More →

Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences

Veterinary Practice
Learn More →

Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma

DVM360
Learn More →

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market

Pulse 2.0
Learn More →

New AI Tool Guides Canine Cancer Treatment

Today's Veterinary Business
Learn More →

Artificial intelligence poised to transform veterinary care

AVMA News
Learn More →

New AI service offers personalized drug response predictions for canine patients with cancer

DVM360
Learn More →

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

TechCrunch
Learn More →

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

USA Today
Learn More →

Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How

Innovative Veterinary Care Journal
Learn More →

ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys

Innovative Veterinary Care Journal
Learn More →

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

International Business Times
Learn More →

New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships

Innovative Veterinary Care Journal
Learn More →

The latest and greatest in canine oncology treatment

DVM360
Learn More →

Get Rid of Your Cancer Treatment Frustrations

Innovative Veterinary Care Journal
Learn More →

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

MedCity News
Learn More →

Be sure to improve your cancer treatment outcomes

Innovative Veterinary Care Journal
Learn More →

Early leukemia and lymphoma remissions in cats and dogs

Innovative Veterinary Care Journal
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)

One Million by One Million
Learn More →

Technological advancement makes cancer treatment easier

Innovative Veterinary Care Journal
Learn More →

Novel veterinary oncologic treatments and diagnostics

dvm360
Learn More →

AI’s Computing Power Could Make Fusion Energy Practical

Lifewire
Learn More →

Don't Guess Your Pet's Condition, Treat It with ImpriMed

Startup to Follow
Learn More →

Interview with ImpriMed CEO & Co-Founder Sungwon Lim

IdeaMensch
Learn More →

This Test Might Make All The Difference When Fighting Lymphoma

Canine Cancer Alliance
Learn More →

ImpriMed: Fighting Cancer — From Dogs To Humans

Startup Thread
Learn More →

At Pear demo day, a who’s who of VCs, and plenty of fresh ideas

TechCrunch
Learn More →